Nisa Investment Advisors’s Pulse Biosciences PLSE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.12K Buy
52
+26
+100% +$480 ﹤0.01% 2727
2025
Q4
$357 Hold
26
﹤0.01% 2859
2025
Q3
$460 Hold
26
﹤0.01% 2866
2025
Q2
$392 Sell
26
-44
-63% -$730 ﹤0.01% 2904
2025
Q1
$1.13K Buy
70
+1
+1% +$19 ﹤0.01% 2609
2024
Q4
$1.2K Buy
69
+23
+50% +$405 ﹤0.01% 2633
2024
Q3
$807 Buy
46
+21
+84% +$358 ﹤0.01% 2623
2024
Q2
$280 Buy
25
+5
+25% +$47 ﹤0.01% 2775
2024
Q1
$174 Buy
+20
New +$184 ﹤0.01% 2664
2022
Q2
Sell
-400
Closed -$2K 2479
2022
Q1
$2K Hold
400
﹤0.01% 2346
2021
Q4
$5K Hold
400
﹤0.01% 2096
2021
Q3
$9 Hold
400
﹤0.01% 2217
2021
Q2
$7 Hold
400
﹤0.01% 2262
2021
Q1
$9 Hold
400
﹤0.01% 2220
2020
Q4
$10K Sell
400
-510
-56% -$8.11K ﹤0.01% 2211
2020
Q3
$11K Buy
910
+460
+102% +$4.95K ﹤0.01% 2106
2020
Q2
$5K Hold
450
﹤0.01% 2010
2020
Q1
$3K Buy
+450
New +$4.67K ﹤0.01% 2011

Other funds holding PLSE

Nisa Investment Advisors's PLSE Position: Q1 2026 in Review

Nisa Investment Advisors increased its Pulse Biosciences (PLSE) stake by 100% in Q1 2026, buying an estimated $480 and bringing the position to 52 shares worth $1.12K. The position accounts for ﹤0.01% of the portfolio, ranked #2727.

Nisa Investment Advisors first reported a position in PLSE in Q1 2020 and has held it in 18 quarters since. The position peaked at $11K in Q3 2020. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Nisa Investment Advisors held 52 shares of Pulse Biosciences worth $1.12K as of Q1 2026.
  • Nisa Investment Advisors bought 26 Pulse Biosciences shares in Q1 2026, an estimated $480.
  • Pulse Biosciences made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q1 2026, its #2727 holding.
  • Nisa Investment Advisors first reported a position in Pulse Biosciences in Q1 2020 and has held it in 18 quarters since.
  • Nisa Investment Advisors's Pulse Biosciences position peaked at $11K in Q3 2020.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Nisa Investment Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.